Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation 131I scintigraphy for thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 2075-2084

  Aide, Nicolas ^a   Heutte, Natacha ^b   Rame, Jean Pierre ^a   Rousseau, Elise ^c   Loiseau, Cédric ^a   Henry Amar, Michel ^a,b   Bardet, Stéphane ^a  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CANCER SURGERY; CERVICAL LYMPH NODE; CHILD; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; IMAGE RECONSTRUCTION; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NECK; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCHOOL CHILD; SCINTILLATION CAMERA; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROTROPIN BLOOD LEVEL; TRACHEA CANCER; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

EID: 66749084470     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2313     Document Type: Article

References (24)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
3. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E 2008 Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941-1959
4. O'Connor MK, Kemp BJ 2006 Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med 36:258-266 (Pubitemid 44300996)
5. Rothman KJ, Boice JD 1982 Epidemiologic analysis with a programmable calculator. Boston, MA: Epidemiology Resources
6. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M 2002 AJCC cancer staging manual. 6th ed. New York: Springer-Verlag
7. Aide N, Lehembre E, Gervais R, Bardet S 2007 Unusual intratracheal metastasis of differentiated thyroid cancer accurately depicted by SPECT/CT acquisition after radioiodine ablation. Thyroid 17:1305-1306
8. Rachinsky I, Driedger A 2007 Iodine-131 uptake in a menstruating uterus: value of SPECT/CT in distinguishing benign and metastatic iodine-positive lesions. Thyroid 17:901-902 (Pubitemid 47606199)
9. von Falck C, Beer G, Gratz KF, Galanski M 2007 Renal metastases from follicular thyroid cancer on SPECT/CT. Clin Nucl Med 32:751-752 (Pubitemid 47294881)
10. Macdonald W, Armstrong J 2007 Benign struma ovarii in a patient with invasive papillary thyroid cancer: detection with I-131 SPECT-CT. Clin Nucl Med 32:380-382 (Pubitemid 46659174)
11. 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 31:1435-1442
12. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, Ludwig Munz D, Felix R 2004 Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 25:1177-1182 (Pubitemid 39614278)
13. 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med 49:1952-1957
14. 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 50:18-23
15. Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M 2008 Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 158:551-560
16. Borson-Chasot F, Bardet S, Bournaud C, Conte-Devolx B, Corone C, D'Herbomez M, Henry JF, Leenhardt L, Peix JL, Schlumberger M, Wemeau JL; Expert Group for French Recommendations for the Management of Differentiated Thyroid Carcinomas of Vesicular Origin, Baudin E, Berger N, Bernard MH, Calzada-Nocaudie M, Caron P, Catargi B, Chabrier G, Charrie A, Franc B, Hartl D, Helal B, Kerlan V, Kraimps JL, Leboulleux S, Le Clech G, Menegaux F, Orgiazzi J, Perié S, Raingeard I, Rodien P, Rohmer V, Sadoul JL, Schwartz C, Tenenbaum F, Toubert ME, Tramalloni J, Travagli JP, Vaudrey C 2008 Guidelines for the management of differentiated thyroid carcinomas of vesicular origin. Ann Endocrinol (Paris) 69:472-486
17. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892-2899 (Pubitemid 44271732)
18. Hay ID, McDougall IR, Sisson JC 2008 Perspective: The case against radioiodine remnant ablation in patients with-differentiated thyroid carcinoma. J Nucl Med 49:1395-1397
19. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC 2004 A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668-3676 (Pubitemid 39089119)
20. 131I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988-994
21. Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A 2008 Spect/Ct. J Nucl Med 49:1305-1319
22. International Commission on Radiological Protection 1987 Radiation dose to patient from radiopharmaceuticals. ICRP Publication 53. Oxford UK: Pergamon Press 1987
23. 124I-PET in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:958-965
24. 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950-957